- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Board Meeting, 11-11-2025: Outcome of Board Meeting
11-11-2025 | 08:28 pm
11-11-2025 | 08:28 pm
Biocon's board has approved Q2 consolidated profit of ₹222 Cr and H1 profit of ₹388.3 Cr. Strategic decisions include early redemption of ₹500 Cr NCDs, acquiring ₹300 Cr CCDs in Biocon Biologics (+0.65% stake), and issuing up to ₹550 Cr Commercial Papers.
No comments yet. Be the first to comment!